As Lina Khan, chair of the Federal Trade Commission, ends her tenure this week the FTC posted a second report in six months ...
Longstanding claims that one of the reasons for high drug prices in the US is the actions of pharmacy benefit management (PBM) companies – the middlemen in the supply chain – are being ...
In 2021, the FDA approved a new insulin drug, Semglee, that was interchangeable with a brand-name insulin called Lantus.
The Iowa Pharmacy Association is calling for reform from Iowa lawmakers after 29 pharmacies closed last year, including some ...
selling a version of Humira for $584 for cash-paying customers without involving a PBM. Typically, PBMs are the entities in the prescription drug supply chain that negotiate net prices and ...